Stress and Anxiety Effects on Overactive Bladder
Sponsor: Vanderbilt University Medical Center
Terminated
Change in status - Update June 2024: Upon guidance from the funding source (NIDDK), this record was pdated to an observational study as it was determined not to be an interventional clinical trial.
Other terminated trials from Vanderbilt University Medical Center
- Nephrolithiasis · Phase NA · May 2025
- Parkinson Disease · Dec 2024
- Hypertension · Phase PHASE4 · Dec 2024
- Crohn's Disease · Phase PHASE2 · Apr 2024
- Depression · Phase NA · Apr 2024
See all terminations from Vanderbilt University Medical Center
Listed as NCT05087810, this observational or N/A phase trial focuses on Anxiety and Overactive Bladder and remains terminated or withdrawn. Sponsored by Vanderbilt University Medical Center, it has been updated 6 times since 2023, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
Phase: NA → None
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jul 2023 — Jul 2024 [monthly]
Recruiting NA
-
Sep 2022 — Jul 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
▶ Show 1 earlier version
-
Nov 2021 — Mar 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Vanderbilt University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .